Showing results (221-230 of 639) with videos related to
Sort By:
Pageof 64
Scientific Reports|August 19, 2017
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinomaRonan Flippot, Roger Mouawad, Jean-Philippe Spano, et al.JTO Clinical and Research Reports|July 31, 2025
Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic CarcinomaChul Kim, Vanya Aggarwal, Gedske Daugaard, et al.Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC networkJordi Remon, Nicolas Girard, Julien Mazieres, et al.Future Oncology (London, England)|February 17, 2025
REZILIENT3: randomized phase III study of first-line zipalertinib plus chemotherapy in patients with EGFR exon 20 insertion-mutated NSCLCJohn V Heymach, Helena A Yu, Benjamin Besse, et al.JCO Precision Oncology|August 1, 2024
Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case ReportsLodovica Zullo, Elora Castanet, Zineb Maaradji, et al.Virchows Archiv : an International Journal of Pathology|January 16, 2013
Thymic carcinomas: clinicopathologic study of 37 cases from a single institutionVincent Thomas de Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 2011
Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meetingCesare Gridelli, Rolf Stahel, Benjamin Besse, et al.Molecular Oncology|April 10, 2012
The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave RoussyMonica Arnedos, Fabrice André, Françoise Farace, et al.Bulletin Du Cancer|April 23, 2021
[Impact of the use of systemic corticosteroid therapy on the effectiveness of immune checkpoint inhibitors]Reda El Hazzaz, Maria Kfoury, Pernelle Lavaud, et al.European Journal of Cancer (Oxford, England : 1990)|March 24, 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancerMatthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.Pageof 64